| Literature DB >> 26664384 |
Masomeh Heshmati1, Sepideh ArbabiBidgoli2, Samideh Khoei3, Seyed Mahdi Rezayat4, Kazem Parivar1.
Abstract
Serious concerns have been expressed about potential health risks of Nano silver containing consumer products (AgNPs) therefore regulatory health risk assessment on such nanoparticles has become mandatory for the safe use of AgNPsinbiomedicalproducts with special concerns to the mutagenic potentials. In this study, we examined the inhibitory and mutagenicity effects of AgNPs in three different sizes of three colloidal AgNPs by Minimal Inhibitory concentration (MIC), Minimal Bactericidal Concentration (MBC) and Bacterial Reverse Mutation Assay (Ames test).All samples were characterized by transmission electron microscopy (TEM), X-Ray Diffraction (XRD) and Dynamic Light Scattering (DLS). DLS analysis showed lack of large agglomeration of the AgNPs and TEM results showed the spherical AgNPswith the average sizes of 15, 19.6, 21.8 nms. Furthermore the XRD analysis showed the crystalline samples with a face centered cubic structure of pure silver.AmestestresultsonColloidal silver nanoparticles showed lack of any mutation in TA100, TA98, YG1029S. typhymuriumstrains.In addition colloidal silver nanoparticles reduced the mutation ratesin all three strains in a concentration dependent manner .This finding creates a new issue in the possible antimutagenic effects of colloidal AgNPsas a new pharmaceutical productwhich should be consideredinfuture studiesby focusing onthephysicochemical properties of AgNPs.Entities:
Year: 2015 PMID: 26664384 PMCID: PMC4673945
Source DB: PubMed Journal: Iran J Pharm Res ISSN: 1726-6882 Impact factor: 1.696
Figure 1characterization of AgNPs by Transmission Electron Microscopy; A)Representative image of A-AgNP; B) Representative image of B-AgNP; C) Representative image of AgNPs water dispersion
Physicochemical characteristics ofAgNPs
| Samples | Concentration | Shape | TEM size(nm2) | Hydrodynamic size(nm3) | Zeta potential mV(pH)2 | Coting Style | Specific Gravity(cP) | pH | PDI |
|---|---|---|---|---|---|---|---|---|---|
| A-AgNP | 4000 | different | 19.6 | 83.7 | -12 | uncoated | 1.14 | 2.5 | 0.608 |
| B-AgNP | 187.5 | spherical | 21.8 | 52.56 | -24.6 | Plant coated | 0.8872 | 4 | 0.516 |
| C-AgNP | 1000 | spherical | 15 | 62.4 | -11.29 | uncoated | ND | 7 | ND |
Determined by Atomic Absorption Spectroscopy (AAS)
Determined by Transmission Electron Microscopy (TEM)
Determined by Dynamic Light Scattering (DLS)
Not determined
Mutagenicity ofA-AgNPs inS. Typhimurium tester strains (TA98, TA100, YG1029)1.
|
|
|
| ||||
|---|---|---|---|---|---|---|
| MIYG1029 | MI TA100 | MI TA98 | YG1029 | TA100 | TA98 | |
| 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 55.3±2.6 | 197±2.08 | 95.6±2.9 | 0.00 |
| 0.02 ± 0.76 | 0.78 ± 0.03 | 0.78 ± 0.03 | 55.3 ± 1.2 | 153 ± 1.7 | 71.3 ± 1.45 | 0.0015 |
| 0.68±0.02 | 0.86±0.01 | 0.79±0.03 | 37.3±1.2 | 170±1.2 | ±1.769.6 | 0.003 |
| 0.84±0.03 | 0.77±0.006 | 0.75±0.02 | 46.3±1.4 | 153±1.73 | 2.03 ±73.3 | 0.006 |
| 0.87±0.05 | 0.79±0.008 | 0.58±0.02 | 48.3±0.88 | 156.3 ± 1.73 | 2.1 54.3± | 0.012 |
| 0.9±0.05 | 0.82±0.004 | 1.00±0.03 | 49.6±0.66 | 162.3±1.85 | 96.3±2.02 | 0.024 |
| 0.64±0.02 | 0.83±0.002 | 0.85±0.01 | 35.6±0.88 | 164.3±1.3 | 79±2.6 | 0.048 |
| 0.73±0.01 | 0.96±0.0034 | o.8±0.01 | 40.6±1.2 | 190.3±1.4 | 74.3±2.02 | 0.097 |
| 0.76±0.05 | 0.87±0.003 | 0.84±0.08 | 42.3±0.88 | 172.6±3.2 | 72.3±1.6 | 0.195 |
| 0.84±0.04 | 0.89±0.01 | 0.98±0.03 | 46.6±1.2 | 176.3±1.6 | 91±2.08 | 0.39 |
| 0.67±0.04 | ND | ND | 37±1.1 | T | T | 0.78 |
| ND | T | 1.56 | ||||
| 3.12 | ||||||
| 13.1±0.35 | 4.8±0.009 | 9.75±0.16 | 726±13.1 | 948±10.7 | 926.6±2.08 | Positive control |
Note: Above data represents the mean number of revertant colonies ± SEM from three independent experiments, each repeated three times.
Note: T denotes the toxic concentration of A-AgNP.Doses higherthan T could not be evaluated against; the positive control (sodiumazidwith 5 µg/ml) and control negative (distilled water) and described as Not Determined (ND).
Highest inhibitory level was 0.58 ± 0.02.
p < 0.001, p < 0.05vs control.
Mutagenicity of C-AgNPs in S.Typhimurium tester strains (TA98, TA100, YG1029)1.
|
|
|
| |||||||
|---|---|---|---|---|---|---|---|---|---|
| MIYG1029 | MI TA100 | MI TA98 | YG1029 | TA100 | TA98 | ||||
| 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 69.9±2.4 | 190.3±2.6 | 197±3.2 | 0.00 | |||
| 0.64±0.05 | 0.9±0.01 | 0.52±0.01 | 45±2.8 | 174.3±2.3 | 95.6±2.3 | 0.0015 | |||
| 0.75±0.01 | 0.8±0.01 | 0.66±0.004 | 52.6±1.4 | 160±0.5 | 50.6±1.7 | 0.003 | |||
| 0.97±0.02 | 0.7±0.01 | 0.85±0.02 | 67.6±1.2 | 143.3±0.3 | 63.6±0.8 | 0.006 | |||
| 0.87±0.03 | 0.7±0.001 | 0.78±0.01 | 61.3±4.09 | 139.6±2.02 | 81.3±1.00 | 0.012 | |||
| 0.71±0.06 | 0.7±0.007 | 0.94±0.01 | 49.3±2.72 | 151.6±0.6 | 75±1.2 | 0.024 | |||
| 0.93±0.017 | 0.8±0.01 | 0.87±0.01 | 65.3±3.17 | 170±0.57 | 90.6±1.4 | 0.048 | |||
| 0.99±0.06 | 0.7±0.01 | 0.97±0.02 | 69.3±2.02 | 135±2.6 | 83.3±1.00 | 0.097 | |||
| 0.85±0.02 | 0.7±0.01 | 0.92±0.04 | 59.3±0.88 | 143±1.7 | 93±0.8 | 0.195 | |||
| 0.70±0.05 | ND | ND | 49±2.3 | T | T | 0.39 | |||
| ND | T | 0.78 | |||||||
| 1.56 | |||||||||
| 3.12 | |||||||||
| 8.3±0.55 | 4.8±0.05 | 9.8±0.28 | 580±25.1 | 926.6±20.8 | 943.3±17.6 | Positive control | |||
Note: Above data represents the mean number of revertant colonies ± SEM from three independent experiments, each repeated three times.
Note:T denotes the toxic concentration of A-AgNP. Doses higher than T could not be evaluated against; the positive control (sodium azidwith 5 µg/ml) and control negative (distilled water) and described as Not Determined (ND).
p < 0.001, p < 0.05vs control.
Mutagenicity of B-AgNP in S. Typhimurium tester strains (TA98, TA100.YG1029)1.
| Mutagenicity Index | Number of revertant colonies/ Plate | Dose | ||||
|---|---|---|---|---|---|---|
| MIYG1029 | MI TA100 | MI TA98 | YG1029 | TA100 | TA98 | |
| 1.00±0.00 | 1.00±0.00 | 1.00±0.00 | 72±1.4 | 196.6±8.81 | 100±0.57 | 0.00 |
|
| 0.78±0.03 | 0.78±0.03 | 55.3±1.2 | 153±1.7 | 71.3±1.45 | 0.0015 |
| 0.72±0.01 | 0.88±0.04 | 0.88±0.04 | 52.3±1.2 | 173.3±2.02 | 61.3±1.45 | 0.003 |
| 0.68±0.01 | 0.73±0.04 | 0.73±0.04 | 50±1.5 | 143.3±2.02 | 64.3±2.1 | 0.006 |
| 0.79±0.06 | 0.98±0.03 | 0.98±0.03 | 57±1.2 | 192.3±1.8 | 73±1.15 | 0.012 |
| 0.86±0.01 | 0.82±0.03 | 0.82±0.03 | 62±2.1 | 161.3±0.8 | 82±1.52 | 0.024 |
| 0.79±0.02 | 0.89±0.03 | 0.89±0.03 | 58±2.6 | 175.3±1.4 | 70.6±1.2 | 0.048 |
| 0.65±0.02 | 0.97±0.03 | 0.97±0.03 | 48±2.5 | 192±1.5 | 84±1.73 | 0.097 |
| 0.82±0.02 | 0.92±0.04 | 0.92±0.04 | 59±2.9 | 180±1.4 | 94.3±2.4 | 0.195 |
| 0.84±0.03 | ND | ND | 61±3.8 | T | T | 0.39 |
| 0.85±0.01 | 62±1.5 | 0.78 | ||||
| ND | T | 1.56 | ||||
| 3.12 | ||||||
| 7.5±0.19 | 4.5±0.14 | 9.2±0.13 | 580±20.8 | 893±12 | 926.6±14.5 | Positive control |
Note: Above data represents the mean number of revertant colonies ± SEM from three independent experiments, each repeated three times.
Note: T denotes the toxic concentration of A-AgNP. Doses higher than T could not be evaluated against; the positive control (sodium azidwith 5 µg/ml) and control negative (distilled water) and described as Not Determined (ND).
p < 0.001, p < 0.05vs control.
Figure 2Comparison of mutagenic effects of AgNPs with positive controlinS. typhimuriumtester strains (TA98, TA100. YG1029).